Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals Ownership Summary

Terns Pharmaceuticals is owned by 63.73% institutional investors, 0.60% insiders, and 35.67% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.94% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.94% of its assets in Terns Pharmaceuticals shares.

TERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Terns Pharmaceuticals	63.73%	0.60%	35.67%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	8.19M	8.94%	$331.05M
Morgan stanley	7.95M	8.66%	$321.00M
Orbimed advisors	7.56M	8.26%	$56.80M
Deep track capital, lp	7.50M	8.18%	$56.29M
Vivo capital	6.90M	7.53%	$51.79M
Commodore capital lp	5.70M	6.22%	$42.81M
Vanguard group	5.52M	6.02%	$223.17M
Blackrock	4.12M	5.53%	$28.06M
Adage capital partners gp	3.94M	4.30%	$29.58M
Nuveen asset management	2.63M	3.38%	$14.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acorn capital advisors	1.97M	7.52%	$14.80M
Superstring capital management lp	789.65K	5.84%	$5.93M
Monashee investment management	197.31K	4.49%	$7.97M
Vivo capital	6.90M	4.17%	$51.79M
Acuta capital partners	502.80K	3.90%	$3.78M
Patient square capital lp	320.00K	2.77%	$12.93M
Eagle health investments lp	275.09K	2.44%	$11.11M
Commodore capital lp	5.70M	2.09%	$42.81M
Deep track capital, lp	7.50M	1.57%	$56.29M
Capricorn fund managers	151.44K	1.47%	$6.12M

Top Buyers

Holder	Shares	% Assets	Change
Commodore capital lp	5.70M	2.09%	5.70M
Lord, abbett	2.71M	0.34%	2.71M
Adage capital partners gp	3.94M	0.05%	2.66M
Blackrock funding, inc. /de	8.19M	0.01%	2.64M
Franklin resources	2.73M	0.03%	1.45M

Top Sellers

Holder	Shares	% Assets	Change
Soleus capital management	212.71K	0.32%	-7.91M
Avidity partners management lp	-	-	-2.13M
Janus henderson group	-	-	-2.00M
Octagon capital advisors lp	-	-	-1.36M
Suvretta capital management	-	-	-1.36M

New Positions

Holder	Shares	% Assets	Change	Value
Commodore capital lp	5.70M	2.09%	5.70M	$42.81M
Lord, abbett	2.71M	0.34%	2.71M	$109.58M
Capital investors	1.06M	0.01%	1.06M	$42.82M
Mariner	542.05K	0.03%	542.05K	$21.90M
Norges bank	395.20K	0.00%	395.20K	$15.97M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
True wealth design	-11.00
Capital performance advisors llp	-23.00
Versant capital management	-36.00
Lgt financial advisors	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	148	-	58,439,899	-34.07%	63	0.68%	114	56.16%	25	-40.48%
Sep 30, 2025	139	6.92%	87,383,371	5.14%	95	1.16%	67	-6.94%	40	33.33%
Jun 30, 2025	129	-7.19%	83,090,778	-0.02%	90	1.10%	71	1.43%	30	-23.08%
Mar 31, 2025	139	-13.66%	83,111,324	-3.50%	90	0.74%	70	-33.33%	39	21.88%
Dec 31, 2024	149	-9.70%	81,944,156	3.09%	105	1.01%	94	-8.74%	31	-18.42%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.19M	2.94%	7.68K
Vanguard US Total Market Shares ETF	2.09M	2.39%	792.70K
iShares Russell 2000 ETF	2.07M	1.90%	2.07M
Franklin Biotechnology Discv A(acc)USD	1.35M	1.24%	136.53K
CREF Stock R1	1.08M	1.23%	-160.00K
US Small-Cap Growth II Equity Comp	1.04M	1.23%	529.45K
T. Rowe Price New Horizons	1.04M	1.23%	-
HBM Healthcare Investments AG Ord	1.15M	1.06%	478.02K
Fidelity Small Cap Growth	877.41K	1.04%	-1.09M
Candriam Eqs L Biotech C USD Cap	1.11M	1.02%	26.75K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 16, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$131.03K
Mar 16, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$550.08K
Feb 17, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$319.96K
Feb 17, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$162.50K
Feb 17, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$89.11K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	10
2025 Q4	-	2
2025 Q3	-	1
2025 Q2	6	1
2025 Q1	-	5

TERN Ownership FAQ

Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals shareholders are primarily institutional investors at 63.73%, followed by 0.60% insiders and 35.67% retail investors. The average institutional ownership in Terns Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Terns Pharmaceuticals falls below.

Who owns the most shares of Terns Pharmaceuticals?

Terns Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (8.19M shares, 8.94%), Morgan stanley (7.95M shares, 8.66%), and Orbimed advisors (7.56M shares, 8.26%). Together, they hold 25.86% of Terns Pharmaceuticals’s total shares outstanding.

Does Blackrock own Terns Pharmaceuticals?

Yes, BlackRock owns 5.53% of Terns Pharmaceuticals, totaling 4.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 28.06M$. In the last quarter, BlackRock increased its holdings by 804.98K shares, a 24.28% change.

Who is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.52% of its assets in 1.97M Terns Pharmaceuticals shares, valued at 14.8M$.

Who is the top mutual fund holder of Terns Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Terns Pharmaceuticals shares, with 2.94% of its total shares outstanding invested in 3.19M Terns Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools